Healthcare Equipment and Supplies
Company Overview of Cellnovo Limited
Cellnovo Limited, a medical technology company, develops and markets mobile diabetes management systems. The company’s mobile diabetes management system includes insulin patch pumps, and activity monitors, as well as cellular enabled wireless touchscreen handsets with integrated blood glucose meters and automatic connectivity to the cloud. Its touchscreen headset device is used for monitoring blood glucose, insulin, carbohydrate intake, and intensity and timing of daily activity, as well as for automatically recording insulin, blood glucose, food, and exercise related information. The company markets its insulin patch pump systems via a direct sales force in the United Kingdom and France, as...
Swansea, SA1 8AS
Key Executives for Cellnovo Limited
Cellnovo Limited does not have any Key Executives recorded.
Cellnovo Limited Key Developments
Cellnovo Limited Announces Sales Results for the Third Quarter and Nine Months Ended September 30, 2016
Oct 20 16
Cellnovo Limited announced sales results for the third quarter and nine months ended September 30, 2016. For the quarter, the company reported sales were €301,218 against €193,662 a year ago.
For the nine months, the company reported sales were €1,053,591 against €261,601 a year ago.
Cellnovo Appoints Rémi Soula as Non-Executive Director
Sep 26 16
Cellnovo Group announced the appointment of Rémi Soula as a Non-Executive Director. Rémi Soula has extensive experience in the French medical technology and biotechnology sector and is one of the three founders of Adocia. M Soula is currently the Director of Business Development and Intellectual Property Director at Adocia and has co-authored more than 30 patents and six scientific publications.
Cellnovo Group Announces Earnings Results for the Half Year Ended June 30, 2016
Sep 13 16
Cellnovo Group announced earnings results for the half year ended June 30, 2016. For the period according to IFRS, the company reported sales of EUR 753,000 against EUR 68,000 a year ago. Operating loss was EUR 7,484,000 against EUR 7,406,000 a year ago. Net loss was EUR 7,221,000 against EUR 7,295,000 a year ago. Net Loss - non IFRS was EUR 7,903,000 against EUR 7,000,000 a year ago. Adjusted loss per share – non-IFRS was EUR 0.73 against EUR 6.77 a year ago.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|